Risks for Anaphylaxis With Intravenous Iron Formulations

Dave, C. V., Brittenham, G. M., Carson, J. L., & Setoguchi, S. (2022). Risks for Anaphylaxis With Intravenous Iron Formulations. Annals of Internal Medicine, 175(11), W143–W144. https://doi.org/10.7326/l22-0283

Authors:

Chintan V Dave

Gary M Brittenham

Jeffrey L Carson

Soko Setoguchi

Affiliated Authors:

Gary M Brittenham

Columbia Affiliation:

Vagelos College of Physicians and Surgeons
- Department of Pediatrics
  Division of Pediatric Hematology, Oncology, and Stem Cell Transplantation
- Department of Medicine

Subjects:

Anaphylaxis (MeSH)

Drug Hypersensitivity (MeSH)

elink

Publication Type:

Article

Unique ID:

10.7326/l22-0283

PMID:

36375166

DOI:

10.7326/l22-0283

Journal:

Annals of Internal Medicine

Publication Date:

2022-11-01

Data Source:

PubMed

Source Link:

View PubMed Record

Record Created:

Tuesday, September 24, 2024 - 15:11